Focus Partners Advisor Solutions’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Focus Partners Advisor Solutions's AMGN Position: Q1 2026 in Review
Focus Partners Advisor Solutions reduced its Amgen (AMGN) stake by 47% in Q1 2026, selling an estimated $1.72M and leaving 5,467 shares worth $1.92M. The position accounts for 0.02% of the portfolio, ranked #361.
Focus Partners Advisor Solutions first reported a position in AMGN in Q1 2022 and has held it in 17 quarters since. The position peaked at $3.36M in Q4 2025. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Focus Partners Advisor Solutions held 5,467 shares of Amgen worth $1.92M as of Q1 2026.
- Focus Partners Advisor Solutions sold 4,811 Amgen shares in Q1 2026, an estimated $1.72M.
- Amgen made up 0.02% of Focus Partners Advisor Solutions's portfolio in Q1 2026, its #361 holding.
- Focus Partners Advisor Solutions first reported a position in Amgen in Q1 2022 and has held it in 17 quarters since.
- Focus Partners Advisor Solutions's Amgen position peaked at $3.36M in Q4 2025.
- 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Focus Partners Advisor Solutions's 13F filing for Q1 2026, filed 13 May 2026.